Quintiles.com

  • Market Access & Commercialization

  • clinical-trials-header
  • Quintiles Clinical Trial

    Do you have the right strategy to differentiate your products and demonstrate value?

    We help you navigate the value substantiation process – from diagnosing stakeholder needs and spheres of influence to performing real-world benefit-risk and competitive analyses – so you can optimize your product’s value platform and gain a preferred position on payer formularies at favorable pricing and reimbursement. The earlier we start collaborating, the more we can help you launch the right product with the right value proposition and evidence packages.

    For smarter market access strategy, our expert consultants offer:

    • A thorough understanding of highly complex and dynamic healthcare systems
    • Broad and deep experience in specialty and primary care products, diagnostics and medical devices
    • Fully integrated solutions from disease modeling through late phase research and patient-centric programs

  • Perspectives on pharma market access 

  • Quintiles Clinical Trails

    Authored by members of Quintiles’ Consulting team in Europe, this white paper outlines the necessary evolution of Portfolio Management to respond to growing demands of stakeholders, in particular, payers expecting that value be demonstrated and better inform decision-making. Read white paper

  • Quintiles Clinical Trails

    Healthcare agencies worldwide routinely use centralized assessments to make informed decisions concerning reimbursement of medicines and other health technologies. These Health Technology Assessments (HTA) can impact a product’s Market Access and should be taken into account when preparing strategic decisions concerning product development, launch and lifecycle management. Read Fact Sheet